Iron and Glial Toxicity

2004 ◽  
pp. 387-398
Keyword(s):  
Author(s):  
André Quincozes-Santos ◽  
Larissa Daniele Bobermin ◽  
Adriano M. de Assis ◽  
Carlos-Alberto Gonçalves ◽  
Diogo Onofre Souza

2001 ◽  
Vol 7 (6) ◽  
pp. 383-388
Author(s):  
C. Malcus-Vocanson ◽  
P. Giraud ◽  
F. Micoud ◽  
V. Janin ◽  
M.H. Charles ◽  
...  

2021 ◽  
Vol 2021 ◽  
pp. 1-14
Author(s):  
Xingyao Pei ◽  
Wenjuan Zhang ◽  
Haiyang Jiang ◽  
Dingkuo Liu ◽  
Xinyu Liu ◽  
...  

Mycotoxins are key risk factors in human food and animal feed. Most of food-origin mycotoxins could easily enter the organism and evoke systemic toxic effects, such as aflatoxin B1 (AFB1), ochratoxin A (OTA), T-2 toxin, deoxynivalenol (DON), zearalenone (ZEN), fumonisin B1 (FB1), and 3-nitropropionic acid (3-NPA). For the last decade, the researches have provided much evidences in vivo and in vitro that the brain is an important target organ on mycotoxin-mediated neurotoxic phenomenon and neurodegenerative diseases. As is known to all, glial cells are the best regulator and defender of neurons, and a few evaluations about the effects of mycotoxins on glial cells such as astrocytes or microglia have been conducted. The fact that mycotoxin contamination may be a key factor in neurotoxicity and glial dysfunction is exactly the reason why we reviewed the activation, oxidative stress, and mitochondrial function changes of glial cells under mycotoxin infection and summarized the mycotoxin-mediated glial cell proliferation disorders, death pathways, and inflammatory responses. The purpose of this paper is to analyze various pathways in which common food-derived mycotoxins can induce glial toxicity and provide a novel perspective for future research on the neurodegenerative diseases.


2013 ◽  
Vol 2013 ◽  
pp. 1-10 ◽  
Author(s):  
Roslyn A. Taylor ◽  
Lauren H. Sansing

Stroke is a leading cause of death worldwide. Ischemic stroke is caused by blockage of blood vessels in the brain leading to tissue death, while intracerebral hemorrhage (ICH) occurs when a blood vessel ruptures, exposing the brain to blood components. Both are associated with glial toxicity and neuroinflammation. Microglia, as the resident immune cells of the central nervous system (CNS), continually sample the environment for signs of injury and infection. Under homeostatic conditions, they have a ramified morphology and phagocytose debris. After stroke, microglia become activated, obtain an amoeboid morphology, and release inflammatory cytokines (the M1 phenotype). However, microglia can also be alternatively activated, performing crucial roles in limiting inflammation and phagocytosing tissue debris (the M2 phenotype). In rodent models, microglial activation occurs very early after stroke and ICH; however, their specific roles in injury and repair remain unclear. This review summarizes the literature on microglial responses after ischemic stroke and ICH, highlighting the mediators of microglial activation and potential therapeutic targets for each condition.


Author(s):  
James Connor ◽  
Poonlarp Cheepsunthorn ◽  
Xuesheng Zhang
Keyword(s):  

2001 ◽  
Vol 7 (6) ◽  
pp. 383-388 ◽  
Author(s):  
C Malcus-Vocanson ◽  
P Giraud ◽  
F Micoud ◽  
V Janin ◽  
M H Charles ◽  
...  

The biochemical and biological characterization of a cytotoxic activity targeting macroglial cells (oligodendrocytes and astrocytes), in moncyte cultures and in CSF of a patient with multiple sclerosis, has previously been described. In further studies, cell-based tests have shown a good correlation between this glial cytotoxic (gliotoxic) activity, in CSF or in urine, and MS. We now present results obtained with urine samples from 102 MS patients, 51 patients with other neurological disease and 35 healthy subjects using a bioassay set up for the detection of an apoptosis-like effect induced in a glial cell-line. Significant gliotoxicity was detected in urine from 74/102 MS patients while only 4/51 neurological controls (P40.001) and never in healthy subjects (P40.001). Given the statistical tendency provided by this bioassay and its technical limitations for routine testing, it is now used for monitoring the molecular characterization of this `gliotoxic factor'. Its replacement by a specific immunoassay could provide more accurate routine techniques for the detection of this biological marker in MS.


Sign in / Sign up

Export Citation Format

Share Document